Malaria Vaccine Pilot Demonstrations ‘Important First Step’ To Determining Role As Preventive Tool

The Lancet: What next for the malaria RTS,S vaccine candidate?
Editorial Board

“On October 23, the Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Committee (MPAC) announced their much-anticipated recommendations for the world’s first malaria vaccine candidate known as RTS,S/AS01. Their decision is not to recommend widespread deployment of the vaccine based on existing evidence, but instead to assess the feasibility of delivering the vaccine and its impact in real-world settings. … The final policy recommendation on the vaccine from WHO is expected by the end of 2015. It has always been stressed that the vaccine could complement — not replace — existing proven malaria interventions. That might still be the case. But it is essential to show efficacy and feasibility outside a trial setting. SAGE and MPAC’s recommendation is an important first step to determine the vaccine’s future” (10/31).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.